Target-Driven Tissue-Agnostic Drug Approvals—a New Path of Drug Development
Roles
Author
Document Type
Article
Publication Date
1-1-2024
Publication Title
Cancers
DOI
10.3390/cancers16142529
Recommended Citation
Thein, K. Z., Myat, Y., Park, B., Panigrahi, K., & Kummar, S. (2024). Target-Driven Tissue-Agnostic Drug Approvals—a New Path of Drug Development. Cancers, 16 (14). https://doi.org/10.3390/cancers16142529